Efficacy of peripheral magnetic stimulation in carpal tunnel syndrome

Efficacy of peripheral magnetic stimulation in carpal tunnel syndrome. A Single-blinded Randomized Controlled Trial.

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

TCTR

Registry ID

TCTR20210209012

Enrollment

Registered

2021-02-09

Start date

2020-11-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who have carpal tunnel syndrome ( mild to moderate degree ) requires non-operative treatments. Carpal tunnel syndrome Peripheral magnetic stimulation nerve conduction study electromyography

Interventions

Peripheral magnetic stimulation Mode Auto 20 , 10 minutes x4 cycle ( 1 cycle/week) on affected hand, place magnetic probe perpendicular on affected hand

Active Comparator Device,Sham Comparator Device

peripheral magnetic stimulation,magnetic stimulation

Eligibility

Sex/Gender

All

Age

20 Years to 79 Years

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with carpal tunnek syndrome, aged 20 to 79 years, Based on data from history, physical examination and nerve conductional study. 2.The diagnosis must be met for carpal tunnel syndrome with severity ranging from mild to moderate degree. 3.If patients who have symptoms both hand. Choose one of the hand that is numb more than. Patients who agree to participated and sign inform consent for this study. 4.Patient who have received a surgical procedure but still has numbness, can participate in research.

Exclusion criteria

Exclusion criteria: Prohibition of peripheral magnetic stimulation, patients with cancer, pregnancy, a patient with a history of epilepsy Or evidence of epilepsy on an EEG test, a patient with a stimulant heart or hearing aid Patients diagnosed with radiculopathy, polyneuropathy, double crush syndrome, diabetic mellitus, history of wrist fracture, inflammatory rheumatic disease or patients who have cognitive impairment and aphasia.

Design outcomes

Primary

Measure	Time frame
severity of symtoms and functinal status at 4 weeks after end of the intervention boston carpal tunnel questionaires	—

Secondary

Measure	Time frame
sensory or motor distal latency and sensory nerve action potential of median nerve at 4 weeks after end of the intervention nerve conduction study	—

Contacts

Public ContactKanintat Senchantichai

Phramongkutklao hospital

stepinw_ice@hotmail.com0914955785

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026